Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

CAPITAL UNIVERSITY

Subsidiary ofCAPITAL UNIVERSITYUEI: KSZUJCGYH5L5CAGE: 0LP17

CAPITAL UNIVERSITY is a federal contractor, registered under UEI KSZUJCGYH5L5 and CAGE code 0LP17. It has been awarded $76,205,600 across 124 federal contracts. Primary work spans Unknown NAICS and Other NAICS codes (2 codes, <0.5% each). Top awarding agencies include Department Of Education, Department Of Health And Human Services (hhs), and Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

KSZUJCGYH5L5

CAGE Code

0LP17

Entity Structure

Corporate Entity (Tax Exempt)

Established

N/A

Business Classifications

Educational InstitutionNon-Profit OrganizationPrivate University or College

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Capital University’s capability profile cannot be substantiated with available award history or contract data. No recent awards, NAICS codes, or agency engagements are documented in the provided record, preventing inference of specific technical services, federal partnerships, or market specializati...

Capital University’s capability profile cannot be substantiated with available award history or contract data. No recent awards, NAICS codes, or agency engagements are documented in the provided record, preventing inference of specific technical services, federal partnerships, or market specialization. As a result, core capabilities, agency experience, and industry focus cannot be accurately described based on performance evidence. The entity is registered under an 8H classification, indicating a small business status under the SBA’s 8(a) Business Development Program, though no additional certifications or accreditations are listed. Located in Columbus, Ohio, the organization maintains a geographic presence in the Midwest federal contracting market but lacks publicly verifiable track records of federal project delivery. Without contract performance data, it is not possible to identify technical domains, service offerings, or mission-critical support areas in which the entity operates. Prospective partners and evaluators are advised that this contractor’s capabilities remain unverified through documented federal contract performance.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Export
- Unknown NAICS$76.2M100%
Others - Other NAICS codes (2 codes, <0.5% each)$17.6K0%
Awards by Agency Over Time
Awards by Place of Performance

Compete with CAPITAL UNIVERSITY

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for CAPITAL UNIVERSITY

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in CAPITAL UNIVERSITY's top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The NIH Small Business Technology Transfer (STTR) grant, solicitation PA-27-102, provides early-stage funding to U.S. small business concerns (SBCs) to conduct research and development for commercial products that align with the NIH mission to enhance health and reduce illness. A mandatory requirement for this program is a formal collaboration between the SBC and a non-profit research institution. The program is structured into Phase I to establish technical feasibility and Phase II to advance toward commercialization, with additional options for Fast-Track and Direct to Phase II applications. Eligible SBCs must be for-profit entities located in the U.S., have no more than 500 employees, and be more than 50 percent owned and controlled by U.S. citizens or permanent residents. Funding limits vary by participating Institute or Center, with Phase I awards typically ranging from 400,000 to 700,000 dollars and Phase II awards reaching up to 3,000,000 dollars. Applications are evaluated via a peer review system based on an overall impact score, focusing on commercial potential, technical merit, and the strength of the commercialization plan. Special requirements include active SAM registration, a Unique Entity Identifier, and strict adherence to cybersecurity incident reporting and clinical trial registration guidelines where applicable. Applications must be submitted through Grants.gov and tracked via eRA Commons, with specific documentation required such as the SF424(R&R) forms and a regulatory plan for clinical trial proposals.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
Solicitation PA-27-100 is a grant opportunity provided by the NIH, CDC, and FDA to support United States small business concerns in conducting research and development for the creation of commercial products. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility, and Phase II advancing the research toward commercialization. Eligible applicants include for-profit entities with 500 or fewer employees that are primarily operated in the U.S. The funding opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, provided the proposed work aligns with the missions of the participating agencies. Funding limits vary by institute, with Phase I awards generally ranging from 400,000 to 700,000 dollars and Phase II awards reaching up to 3,000,000 dollars. Applications are evaluated via a peer review system based on scientific and technical merit, significance, and the suitability of the business environment. Key requirements include maintaining active SAM.gov registration with a Unique Entity Identifier and adhering to strict cybersecurity incident reporting protocols. While clinical trials are generally permitted, they are explicitly excluded for certain components, including all FDA participating components and several NIH institutes such as NIAMS and NIDCR. The deadline for responses is April 6, 2027.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The SBIR/STTR Commercialization Readiness Pilot (CRP) Program, solicitation PAR-27-098, is a funding opportunity provided by the National Institutes of Health (NIH) to help United States-based small business concerns transition technology from late-stage research and development to full commercialization. This program is specifically designed for recipients of prior or active NIH SBIR or STTR Phase II or Phase IIB Strategic Breakthrough awards. It supports activities that bridge the gap to market, including independent replication of key studies, manufacturing scale-up, regulatory strategy and submissions, and clinical trials, provided the project aligns with the mission of a participating NIH Institute, Center, or Office. Notably, the program allows for significant outsourcing to contract research organizations, provided the small business maintains a substantial role in project oversight and management. Eligible applicants must be for-profit small businesses with no more than 500 employees and must maintain active registrations in the System for Award Management (SAM) and the SBA Company Registry. Funding ceilings vary by participating institute, ranging from 500,000 dollars to 2 million dollars, or following SBA guidelines for certain centers. Applications are evaluated through the NIH peer review system based on scientific and technical merit, commercial potential, and relevance to program priorities. Key submission requirements include a detailed regulatory plan, a CRP progress report, and a budget that excludes patent or FDA filing fees. The maximum project period is three years, and the solicitation expires on April 6, 2029.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 6 months
View Details